- Home
- TNGX vs ARQ Comparison
TNGX vs ARQ Comparison
Compare TNGX & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ARQ
- Stock Information
- Founded
- TNGX 2014
- ARQ 1996
- Country
- TNGX United States
- ARQ United States
- Employees
- TNGX N/A
- ARQ N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- TNGX Health Care
- ARQ
- Exchange
- TNGX Nasdaq
- ARQ NYSE
- Market Cap
- TNGX 317.4M
- ARQ 269.8M
- IPO Year
- TNGX N/A
- ARQ N/A
- Fundamental
- Price
- TNGX $3.35
- ARQ $6.35
- Analyst Decision
- TNGX Strong Buy
- ARQ Strong Buy
- Analyst Count
- TNGX 8
- ARQ 1
- Target Price
- TNGX $13.14
- ARQ $10.00
- AVG Volume (30 Days)
- TNGX 757.1K
- ARQ 228.2K
- Earning Date
- TNGX 03-17-2025
- ARQ 03-12-2025
- Dividend Yield
- TNGX N/A
- ARQ N/A
- EPS Growth
- TNGX N/A
- ARQ N/A
- EPS
- TNGX N/A
- ARQ N/A
- Revenue
- TNGX $43,383,000.00
- ARQ $110,023,000.00
- Revenue This Year
- TNGX $27.73
- ARQ $12.76
- Revenue Next Year
- TNGX N/A
- ARQ $30.28
- P/E Ratio
- TNGX N/A
- ARQ N/A
- Revenue Growth
- TNGX 15.67
- ARQ 16.44
- 52 Week Low
- TNGX $2.59
- ARQ $3.00
- 52 Week High
- TNGX $12.89
- ARQ $8.26
- Technical
- Relative Strength Index (RSI)
- TNGX 58.01
- ARQ 44.26
- Support Level
- TNGX $2.82
- ARQ $6.14
- Resistance Level
- TNGX $3.20
- ARQ $6.47
- Average True Range (ATR)
- TNGX 0.20
- ARQ 0.21
- MACD
- TNGX 0.05
- ARQ -0.00
- Stochastic Oscillator
- TNGX 97.40
- ARQ 33.72
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.